Literature DB >> 34031609

BAR-Seq clonal tracking of gene-edited cells.

Samuele Ferrari1,2, Stefano Beretta3, Aurelien Jacob3,4, Davide Cittaro5, Luisa Albano3, Ivan Merelli3,6, Luigi Naldini3,7, Pietro Genovese3,8.   

Abstract

Gene editing by engineered nucleases has revolutionized the field of gene therapy by enabling targeted and precise modification of the genome. However, the limited availability of methods for clonal tracking of edited cells has resulted in a paucity of information on the diversity, abundance and behavior of engineered clones. Here we detail the wet laboratory and bioinformatic BAR-Seq pipeline, a strategy for clonal tracking of cells harboring homology-directed targeted integration of a barcoding cassette. We present the BAR-Seq web application, an online, freely available and easy-to-use software that allows performing clonal tracking analyses on raw sequencing data without any computational resources or advanced bioinformatic skills. BAR-Seq can be applied to most editing strategies, and we describe its use to investigate the clonal dynamics of human edited hematopoietic stem/progenitor cells in xenotransplanted hosts. Notably, BAR-Seq may be applied in both basic and translational research contexts to investigate the biology of edited cells and stringently compare editing protocols at a clonal level. Our BAR-Seq pipeline allows library preparation and validation in a few days and clonal analyses of edited cell populations in 1 week.

Entities:  

Year:  2021        PMID: 34031609     DOI: 10.1038/s41596-021-00529-x

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  50 in total

Review 1.  Cellular barcoding: lineage tracing, screening and beyond.

Authors:  Justus M Kebschull; Anthony M Zador
Journal:  Nat Methods       Date:  2018-10-30       Impact factor: 28.547

2.  Clonal tracking using embedded viral barcoding and high-throughput sequencing.

Authors:  Charles Bramlett; Du Jiang; Anna Nogalska; Jiya Eerdeng; Jorge Contreras; Rong Lu
Journal:  Nat Protoc       Date:  2020-03-04       Impact factor: 13.491

3.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors:  M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

4.  Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans.

Authors:  Serena Scala; Luca Basso-Ricci; Francesca Dionisio; Danilo Pellin; Stefania Giannelli; Federica Andrea Salerio; Lorena Leonardelli; Maria Pia Cicalese; Francesca Ferrua; Alessandro Aiuti; Luca Biasco
Journal:  Nat Med       Date:  2018-10-01       Impact factor: 53.440

5.  Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

Authors:  Alessandro Aiuti; Luca Biasco; Samantha Scaramuzza; Francesca Ferrua; Maria Pia Cicalese; Cristina Baricordi; Francesca Dionisio; Andrea Calabria; Stefania Giannelli; Maria Carmina Castiello; Marita Bosticardo; Costanza Evangelio; Andrea Assanelli; Miriam Casiraghi; Sara Di Nunzio; Luciano Callegaro; Claudia Benati; Paolo Rizzardi; Danilo Pellin; Clelia Di Serio; Manfred Schmidt; Christof Von Kalle; Jason Gardner; Nalini Mehta; Victor Neduva; David J Dow; Anne Galy; Roberto Miniero; Andrea Finocchi; Ayse Metin; Pinaki P Banerjee; Jordan S Orange; Stefania Galimberti; Maria Grazia Valsecchi; Alessandra Biffi; Eugenio Montini; Anna Villa; Fabio Ciceri; Maria Grazia Roncarolo; Luigi Naldini
Journal:  Science       Date:  2013-07-11       Impact factor: 47.728

6.  Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells.

Authors:  Chuanfeng Wu; Brian Li; Rong Lu; Samson J Koelle; Yanqin Yang; Alexander Jares; Alan E Krouse; Mark Metzger; Frank Liang; Karin Loré; Colin O Wu; Robert E Donahue; Irvin S Y Chen; Irving Weissman; Cynthia E Dunbar
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

Review 7.  Gene therapy returns to centre stage.

Authors:  Luigi Naldini
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

8.  Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding.

Authors:  Rong Lu; Norma F Neff; Stephen R Quake; Irving L Weissman
Journal:  Nat Biotechnol       Date:  2011-10-02       Impact factor: 54.908

9.  Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking.

Authors:  Samuele Ferrari; Aurelien Jacob; Stefano Beretta; Giulia Unali; Luisa Albano; Valentina Vavassori; Davide Cittaro; Dejan Lazarevic; Chiara Brombin; Federica Cugnata; Anna Kajaste-Rudnitski; Ivan Merelli; Pietro Genovese; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2020-06-29       Impact factor: 54.908

10.  Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

Authors:  Alessandra Biffi; Eugenio Montini; Laura Lorioli; Martina Cesani; Francesca Fumagalli; Tiziana Plati; Cristina Baldoli; Sabata Martino; Andrea Calabria; Sabrina Canale; Fabrizio Benedicenti; Giuliana Vallanti; Luca Biasco; Simone Leo; Nabil Kabbara; Gianluigi Zanetti; William B Rizzo; Nalini A L Mehta; Maria Pia Cicalese; Miriam Casiraghi; Jaap J Boelens; Ubaldo Del Carro; David J Dow; Manfred Schmidt; Andrea Assanelli; Victor Neduva; Clelia Di Serio; Elia Stupka; Jason Gardner; Christof von Kalle; Claudio Bordignon; Fabio Ciceri; Attilio Rovelli; Maria Grazia Roncarolo; Alessandro Aiuti; Maria Sessa; Luigi Naldini
Journal:  Science       Date:  2013-07-11       Impact factor: 47.728

View more
  2 in total

1.  Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.

Authors:  Attya Omer-Javed; Gabriele Pedrazzani; Luisa Albano; Sherash Ghaus; Claire Latroche; Maura Manzi; Samuele Ferrari; Martina Fiumara; Aurelien Jacob; Valentina Vavassori; Alessandro Nonis; Daniele Canarutto; Luigi Naldini
Journal:  Cell       Date:  2022-05-25       Impact factor: 66.850

2.  Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.

Authors:  Samuele Ferrari; Aurelien Jacob; Daniela Cesana; Marianne Laugel; Stefano Beretta; Angelica Varesi; Giulia Unali; Anastasia Conti; Daniele Canarutto; Luisa Albano; Andrea Calabria; Valentina Vavassori; Carlo Cipriani; Maria Carmina Castiello; Simona Esposito; Chiara Brombin; Federica Cugnata; Oumeya Adjali; Eduard Ayuso; Ivan Merelli; Anna Villa; Raffaella Di Micco; Anna Kajaste-Rudnitski; Eugenio Montini; Magalie Penaud-Budloo; Luigi Naldini
Journal:  Cell Stem Cell       Date:  2022-10-06       Impact factor: 25.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.